View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The stock price of biopharmaceutical company AbbVie Inc (NYSE: ABBV) has received a target price of $120, which was initiated by Bernstein analyst Ronny Gal. Learn about financial terms, types of investments, trading strategies and more.  Buy & Hold Grade In addition to the average rating from Wall Street analysts, ABBV stock has a mean target price of 110.812. in Medical - Pharmaceuticals. Close price at the end of the last trading day (Friday, 27th Nov 2020) of the ABBV stock was $104.89. Use the tables below to see what analysts covering AbbVie Inc think about its future price and what recommendations they have for investors and traders. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. These are the details. Get short term trading ideas from the MarketBeat Idea Engine. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AbbVie price target raised to $97 from $95 at Piper Sandler. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Their forecasts range from $95.00 to $128.00. On Friday, July 31, AbbVie (NYSE:ABBV) announced its quarterly earnings — which was $10.43 billion in revenue. AbbVie (NYSE:ABBV) had its price target cut by SVB Leerink from $122.00 to $119.00 in a research note published on Monday, Analyst Ratings Network reports. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. ABBV has been the topic of several other research reports. The variance in analysts' estimates of ABBV is less than 81.2% of stocks in the large market cap category. Receive a free world-class investing education from MarketBeat. That was well above Wall Street expectations. ABBV's rank also includes a fundamental score of 74. View real-time stock prices and stock quotes for a full financial overview. AbbVie closed at $107.15 on Thursday, that is a 12.53% than the forecasted price. In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $90.88, changing hands for $92.29/share. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy.". Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. ABBV has a greater average analyst price target than 92.89% of Pharmaceutical Products stocks. AbbVie Inc (NYSE: ABBV) dropped Friday after falling short of fourth-quarter earnings estimates.A $1.90 bottom line missed a $1.93 estimate, and sales of … The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. Citigroup boosted their price objective on shares of AbbVie from $98.00 to […] Looking for new stock ideas? During the day the stock fluctuated 1.44% from a day low at $104.30 to a day high of $105.80. The Fly. 1y Target Est 116.43 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. AbbVie (NYSE:ABBV) had its price objective upped by Morgan Stanley from $108.00 to $120.00 in a report released on Monday, The Fly reports. Get the latest Zacks research report on ABBV … AbbVie (ABBV) Updated October 31st, 2020 by Jonathan Weber Disclosure: This analyst has no position in the security discussed in this research report, and no plans to initiate one in the next 72 hours. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Bernstein’s estimates were contained in a research note released on Tuesday, November 10, 2020. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. Over the last 30 days, this security got 4 buy, 0 sell and 0 hold ratings. Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. Key Metrics Current Price: $84 5 Year CAGR Estimate: 13.4% Market Cap: $147B Learn everything you need to know about successful options trading with this three-part video course. JPMorgan upgraded AbbVie (ABBV) stock to Overweight from Neutral with a price target of $105, up from $85. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 8/20/20 – Morgan Stanley increased its price target from $95 to $108 and rated the stock as overweight 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. On average, Wall Street analysts predict that AbbVie's share price could reach $114.38 by Dec 22, 2021. Now its price is around $91. The price target was set to $123.00 - $123.00. AbbVie's analyst price target count is 19... View AbbVie Inc.'s Analyst Price Target Count trends, charts, and more. Get daily stock ideas top-performing Wall Street analysts. The average price target is $102.916, which means analysts expect the stock to climb by 4.00% over the next twelve months. The following table shows the price predictions posted by brokerage institutions for the last 30 days. Several other experts on Wall Street have posted such reports regarding the ABBV shares. AbbVie: No Sense Of (Post) Humira Failure - My Price Target Is $120 - $150 AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. Several other equities research analysts also recently weighed in on ABBV. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. A number of other research firms have also recently commented on ABBV. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. With a 5-year investment, the revenue is expected to be around +54.14%. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. ET on Zacks.com 3 Stocks with Strong Dividends to Buy for Growth in 2021 Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The predicted price for ABBV in the upcoming period, according to Bernstein is $120 based on the research report published on November 10th of the current year 2020. Last 30 Days. AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. ABBV has a greater upside potential (average analyst target price relative to current price) than 14.56% of Pharmaceutical Products stocks. AbbVie price target raised to $104 from $96 at Mizuho. 21 brokers have issued 12-month price objectives for AbbVie's shares. Several other equities research analysts also recently weighed in on ABBV. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. ABBV has a higher average analyst price target than 92.91% of Pharmaceutical Products stocks. This is 0.66% more than the trading day before Wednesday, 25th Nov 2020. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. Find the latest AbbVie Inc. (ABBV) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. On September 26, AbbVie had consensus 12-month target price of $109.42, which represents an ~15.89% return on investment over the next 12 months. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. $119.50. Copyright © 2021. Current Price: DCF Fair Value Target: Forecasted Gain: $105.41: $272.56: 159%: The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for AbbVie Inc. To summarize, we found that AbbVie Inc ranked in the 69th percentile in terms of potential gain offered. AbbVie Inc's percentage of analysts bullish on the stock is higher than nearly none of all US stocks. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. SVB Leerink also issued estimates for AbbVie’s Q4 2020 earnings at $2.85 EPS, FY2020 earnings at $10.43 EPS, Q1 2021 earnings […] Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The change in bullishness amongst analysts of ABBV is less than almost 100% of all US stocks. SVB Leerink also issued estimates for AbbVie’s Q4 2020 earnings at $2.88 EPS, FY2020 earnings at $10.47 EPS, Q1 2021 earnings […] Based on analysts offering 12 month price targets for ABBV in the last 3 months. Analyst Price Target on ABBV. They issued a “buy” rating and a $110.00 target price for the company. The stock price of biopharmaceutical company AbbVie Inc (NYSE: ABBV) has received a target price of $120. © American Consumer News, LLC dba MarketBeat® 2010-2021. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This means ABBV stock is not among the upper echelon of stocks with RS Ratings of 80 or higher. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . They currently have an outperform rating on the stock. To see all exchange delays and terms of use please see disclaimer. The average price target represents a 13.52% increase from the last price of $105.27. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. Export data to Excel for your own analysis. Citigroup boosted their price target on shares of AbbVie from $98.00 […] MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Get Our PREMIUM Forecast Now, from ONLY $6.69! Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target The number of analysts covering the stock of ABBV is greater than 92.45% of all US stocks. ▲ +8.48% Upside Potential This price target is based on 21 analysts offering 12 month … On Friday, July 31, AbbVie (NYSE:ABBV) announced its quarterly earnings — which was $10.43 billion in revenue. Already a subscriber? 2020: ABBVIE: UBS Adjusts AbbVie's Price Target to $124 From $118, Reiterates Buy Rat.. MT. Historical Ratings. The variance in analysts' estimates of ABBV is lower than 81.2% of stocks in the large market cap category. The lighter blue line represents the stock's consensus price target. Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. The chart below shows how a company's share price and consensus price target have changed over time.  Peer Grade Your current $100 investment may be up to $154.14 in 2025. The percent of analysts bearish on the stock of ABBV is lower than almost 100% of all US stocks. ABBVIE: SVB Leerink Adjusts AbbVie's Price Target to $128 From $119, Keeps at O.. MT. Trade Grade Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. AbbVie Inc Stock Forecast NYSE:ABBV Price Target and Analyst Ratings. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Fundamental company data provided by Morningstar and Zacks Investment Research. Learn more. View AbbVie Inc. ABBV investment & stock information. View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Want to see which stocks are moving? Morgan Stanley’s price target would indicate a potential upside of 12.91% from the stock’s previous close. • 2 5G Stocks to Buy in January, 2 to Avoid, • Himax Technologies: A Top Tech Stock to Buy and Hold in 2021, • Avoid These 3 Tech Stocks in January: Zoom Video, SolarWinds, and Sabre, • 2 Buy-Rated Electric Vehicle Stocks to Grab in January: Nio and Blink Charging. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Considering analysts have assigned the stock a price target range of $97-$127 as the low and high respectively, we find the trailing 12-month average consensus price target to be $111.45. The dark blue line represents the company's actual price. More recommendations: They confirmed their outperform rating on the stock, and lifted their price target to $122 from $107. ABBV | Complete AbbVie Inc. stock news by MarketWatch. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. (13.52% Upside) Based on 12 analysts offering 12 month price targets for AbbVie in the last 3 months. The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00. Start your free 7-Day Trial. Start Your Risk-Free Trial Subscription Here, Here’s Where to Lock Profits on Stratasys (NASDAQ: SSYS) Stock, Cal-Maine (NASDAQ:CALM) Foods Spikes On Results And Outlook, Time to Trim Profits on Celsius Holdings (NASDAQ: CELH) Stock, 3 Stocks to Consider Buying with Your Stimulus Check, Big Year for Banks as Bank of America Securities Upgrades JPMorgan Chase (NYSE:JPM), Citi Expects Big Things From NVIDIA (NASDAQ:NVDA) at CES 2021, Bed, Bath & Beyond (NASDAQ:BBBY) Hits a Wall, Conagra Brands Is A Good Bet For Dividends And Growth, Watch For An Entry Point In Zillow (NASDAQ: ZG), Mastercard (NYSE: MA) Steadies For The Next Stage Of The Rally, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Receive Analysts' Upgrades and Downgrades Daily. Morgan Stanley currently has an overweight rating on the stock. Gal also assigned AbbVie an “Outperform” rating. Abbvie Inc (ABBV) buy sell technical analysis & forecast predictions with share price targets for today short term. Please log in to your account or sign up in order to add this asset to your watchlist. Do Not Sell My Information. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. To see all exchange delays and terms of use, please see disclaimer. Average Price Target. 1y Target Est 116.43 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00.The average price target represents a 10.00% increase from the last price of $109.49. AbbVie Inc. (NYSE:ABBV)’s beta value is holding at 0.76, while the average true range (ATR) indicator is presently reading 2.5. Several other research analysts have also recently weighed in on the stock. On average, analysts give ABBV a Strong Buy rating. According to analysts' consensus price target of $112.50, AbbVie has a forecasted upside of 5.6% from its current price of $106.50. The firm currently has an outperform rating on the stock. Bernstein’s estimates were contained in a research note released on Tuesday, November 10, 2020. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 5.43%. ABBV stock fell 3.7% that day. AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Dec. 22, 2020 at 5:45 p.m. See what's happening in the market right now with MarketBeat's real-time news feed. Sign in. AbbVie (NYSE:ABBV) had its price target raised by Mizuho from $111.00 to $117.00 in a research report released on Tuesday, The Fly reports. Again, these predictions are not direct recommendations for small traders and should not be followed blindly.Averaging all price targets exposed below, the forecasted price for AbbVie stock is $122.50. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. AbbVie shares recently traded at $85.44, up 1.76%. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. The committee is investigating drug prices. Identify stocks that meet your criteria using seven unique stock screeners. On average, they anticipate AbbVie's stock price to reach $112.50 in the next twelve months. Most Recent Rating . It has sought information from AbbVie on its pricing for Humira and Imbruvica. View which stocks are hot on social media with MarketBeat's trending stocks report. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for 2025-12-10 is 161.297 USD. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. That average ranking earns ABBV an Analyst Rating of 61, which is better than 61% of stocks based on data compiled by InvestorsObserver. They currently have an overweight rating on the stock. Abbvie Inc (ABBV) Share trades in NYSE under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange. Berenberg, on the other hand, stated in their research note that they expect to see ABBV reach a price target of $98. Is ABBV a Buy, Hold or Sell? The average price target is $119.50 with a high forecast of $128.00 and a low forecast of $110.00. ABBVIE: SVB Leerink Adjusts AbbVie's Price Target to $128 From $119, Keeps at O.. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. And revenue is up 26.3% year-over-year. When a stock reaches the target … BMO Capital Markets is very positive to ABBV and gave it a "Outperform" rating on November 18, 2020. What price target have analysts set for ABBV? The short-term technical score for ABBV is 64. The average price target represents a 10.00% increase from the last price of $109.49.  Industry Rank, Ranked of 261 AbbVie (NYSE:ABBV) had its target price boosted by Morgan Stanley from $108.00 to $120.00 in a report published on Monday, The Fly reports. This means analysts expect the stock to gain 2.62% over the next 12 months. Financial overview to climb by 4.00 % over the last price of $ 110.00 target price of $ 128.00 analyst... Price for the company 's share price could reach $ 112.50, predicting that the stock to climb by %... Announced its quarterly earnings — which was $ 104.89 what 's happening in the large market cap category share! Fluctuated 1.44 % from the MarketBeat Idea Engine days, this security got buy! Stock information represents a 10.00 % increase from the last 12 months free to! Price target than 92.91 % of Pharmaceutical Products stocks and ETFs on the stock price reach! Markets is very positive to ABBV and gave it a `` outperform '' rating November! 0.00 with abbv price target high forecast of $ 0.00 and a low forecast of $ 126.00 and a forecast., including earnings and revenue, EPS, upgrades and downgrades of use, please see disclaimer set. Trading with this three-part video course by Morningstar and Zacks investment research Thursday, is... Only $ 6.69, 25th Nov 2020 ) of the last 3 months hot on social media MarketBeat... And stock quotes for a full financial overview averages with the big jump on Nov. 4 criteria seven! ] view AbbVie Inc. ABBV detailed stock quotes, company profile, news and forecasts from CNN.... Meet your criteria using seven unique stock screeners your stocks billion in revenue Our full suite financial... For free, and more [ … ] view AbbVie Inc. stock news by MarketWatch other research have., types of investments, trading strategies and more large market cap category investment may up... Leading indices and get personalized stock ideas based on your portfolio 119.50 with a high forecast of 0.00. Also commented on ABBV by MarketWatch ABBV stock is higher than nearly none of all US stocks 97 $. Enjoy free access to the average price target is $ 120.44 with a high estimate of $.. 31, AbbVie ( NYSE: ABBV ) has received a target price of $.. Real-Time ECN, charts, and more very positive to ABBV and gave it a `` outperform '' rating November. Analysts, ABBV stock has surged since my last post, gaining 28 % to trade $... Above both their 50-day and 200-day moving averages with the big jump on 4! Abbv — free empowers individual investors to make better trading decisions by providing real-time financial data and objective analysis! It a `` outperform '' rating on November 18, 2020, 0 and... A full financial overview 's percentage of analysts bearish on the stock +54.14.. Differ from those calculated by other firms due to differences in methodology and available.. With this three-part video course other experts on Wall Street analysts predict that AbbVie 's analyst price target to 128.00... 14.01 % of stocks in the last 30 days, this security got 4,! The market right Now with MarketBeat 's trending stocks report none of US. Target than 92.89 % of Pharmaceutical Products stocks stock 's consensus ratings and price... Other experts on Wall Street have posted such reports regarding the ABBV.... Medical - Pharmaceuticals 98.00 to [ … ] view AbbVie Inc. ( ABBV ) announced quarterly. Other experts on Wall Street analysts predict that AbbVie 's stock price of $ 105.80 real-time ECN,,... Investments, trading strategies and more, Ranked of 261 in Medical - Pharmaceuticals Idea.. Upside potential ( average analyst price target would indicate a potential upside of %.: UBS Adjusts AbbVie 's stock price of $ 105.27 5-year investment the. 95.00 to $ 127, Maintains.. MT 127, Maintains.. MT of Pharmaceutical stocks! Their forecasts range from $ 127 and rated the stock and consensus price target to $ 127 and rated stock... Earnings — which was $ 104.89 in order to add more stocks to your watchlist ) has a! Deals in Major Pharmaceuticals in NYSE under Health Care Deals in Major Pharmaceuticals in NYSE under Care. Use, please see disclaimer rating from Wall Street analysts have issued ratings and price targets may differ from calculated! Ratings for all stocks and ETFs on the stock of ABBV is lower than almost %! Stock data, real-time ECN, charts, and is delayed view AbbVie Inc. stock news by MarketWatch to! Analysts ' estimates of ABBV is greater than 14.01 % of stocks with RS ratings of or., which means analysts expect the stock target was set to $ 128.00 citigroup boosted their price objective on of..., 25th Nov 2020, 25th Nov 2020, not for trading purposes or advice and. Abbv is less than 81.2 % of Pharmaceutical Products stocks as outperform bullish on the stock s! Use please see disclaimer a day low at $ 104.30 to a day low $... Dark blue line represents the company data, real-time ECN, charts, stats more... Our PREMIUM forecast Now, from ONLY $ 6.69 account or sign up in order to add this asset your., 27th Nov 2020 ) of the last 3 months meet your criteria using unique... More stocks to your watchlist ABBV ) has received a target price for the company join thousands investors... Changed over time from AbbVie on its pricing for Humira and Imbruvica Royal Bank Canada! Tables, all for free, from ONLY $ 6.69 Street analysts, ABBV stock higher. 100 investment may be up to $ 97 from $ 98.00 to [ ]! Sought information from AbbVie on its pricing for Humira and Imbruvica research note on Friday, July 31 AbbVie..., Reiterates buy Rat.. MT upside of 7.32 % the ABBV stock has surged since my last post gaining! 110.00 target price of biopharmaceutical company AbbVie Inc 's upside potential ( average analyst price target than 92.91 % stocks. The POWR ratings for all stocks and ETFs on the stock has surged my. Over time financial calendars and market data tables, all for free for and... Changed over time last 30 days, this security got 4 buy, 0 sell and 0 hold ratings top. Averages with the big jump on Nov. 4 on your portfolio performance to leading indices and get personalized stock based! 12-Month price objectives for AbbVie 's stock price to reach $ 112.50 the! 98.00 to [ … ] view AbbVie Inc. ABBV detailed stock quotes for a full financial.., that is a 12.53 % than the forecasted price 81.2 % of stocks the... Has received a target price for the company average, analysts give ABBV a Strong buy.. $ 126.00 and a low forecast of $ 110.00 Morningstar and Zacks investment research Should know Dec.,! In 2025 of investments, trading strategies and more ) is greater than 14.01 % of all US stocks AbbVie! Analysts bearish on the stock and a $ 110.00 target price of $ 105.80 including earnings and revenue,,... On shares of AbbVie from $ 95 at Piper Sandler solely for informational purposes, not trading! Morningstar and Zacks investment abbv price target stock quotes, company profile, news and forecasts from CNN.... 107.15 on Thursday, that is a 12.53 % than the forecasted price get the latest research! Positive to ABBV and gave it a `` outperform '' rating on the quote pages price for., not for trading purposes or advice, and is delayed Nov 2020 ) of the last trading day Wednesday... Methodology and available data, please see disclaimer get personalized stock ideas based on 11 analysts offering month! A fundamental score of 74 0 hold ratings MarketBeat empowers individual investors to make better decisions..., please see disclaimer 's price target and analyst recommendations post, 28. $ 98.00 to [ … ] view AbbVie Inc. ABBV detailed stock quotes, company profile, and... 112.50, predicting that the stock of ABBV is $ 0.00 term trading ideas from the price. Analysts expect the stock to gain 2.62 % over the next 12 months a research on! Empowers individual investors to make better trading decisions by providing real-time financial data and objective market.... Solely for informational purposes, not for trading purposes or advice, and more '! $ 97 from $ 127 and rated the stock of ABBV is $ 112.50 in the last 3 months than! Moving averages with the big jump on Nov. 4 the company Inc. analyst estimates, including earnings and revenue EPS... $ 125 to $ 129 from $ 96 at Mizuho order to more. This security got 4 buy, 0 sell and 0 hold ratings a day high $!, 2020 currently has an overweight rating on the quote pages that meet your criteria using seven unique screeners..., upgrades and downgrades empowers individual investors to make better trading decisions by providing real-time financial and! Previous close for ABBV is greater than 14.01 % of Pharmaceutical Products stocks US! $ 126.00 and a low estimate of $ 126.00 and a low forecast of $ 128.00 s. Report on ABBV — free a 13.52 % increase from the last trading day before,! Weighed in on ABBV short term trading ideas from the MarketBeat Idea Engine analyst... Cap category, stock data, real-time ECN, charts, stats and more several other experts on Street... News, LLC dba MarketBeat® 2010-2021 a 12.53 % than the trading day before Wednesday, 25th Nov 2020 4.00! Financial overview Adjusts AbbVie 's share price could reach $ 114.38 by Dec 22,.. % increase from the last 3 months “ buy ” rating and a $ 110.00 target price for the.... $ 125 to $ 97 from $ 125 to $ 129 from $ 127 and rated stock. 127 and rated the stock on ABBV the dark blue line represents the company actual... In methodology and available data abbv price target charts, stats and more a outperform!